Works about GEMCITABINE

Results: 567

miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer.

Published in:

General Physiology & Biophysics, 2025, v. 44, n. 2, p. 175, doi. 10.4149/gpb_2024047

By:

Jiayun Ge;
Zhihong Zhang;
Guohui Shao;
Dong Wei;
Bo Tang;
Zhitian Shi;
Renchao Zou;
Xin Wang

Publication type:

Article

Correction: Long non-coding RNA MIR4435-2HG modulates pancreatic cancer stem cells and chemosensitivity to gemcitabine by targeting the miR-1252-5p/STAT1.

Published in:

2025

By:

Xie, Baocheng;
Wu, Peishan;
Liu, Hongyu;
Yang, XiangDi;
Huang, Linxuan

Publication type:

Correction Notice

Conversion Surgery Performed Following Durvalumab Combined With Gemcitabine and Cisplatin in Cholangiocarcinoma: A Case Report.

Published in:

In Vivo, 2025, v. 39, n. 3, p. 1724, doi. 10.21873/invivo.13974

By:

YOSHIYUKI TAGAYASU;
RIN YAMADA;
KOSUKE KANEMITSU;
YOSHIHIKO KONDO;
RUMI ITOYAMA;
HIROMITSU HAYASHI;
YOSHIHIRO KOMOHARA;
MASAAKI IWATSUKI

Publication type:

Article

Gemcitabine-related fatal cholestatic hepatitis.

Published in:

Oncology in Clinical Practice (2450-1654), 2025, v. 21, n. 2, p. 166, doi. 10.5603/ocp.98757

By:

Yıldız, Oğuzhan;
Eryilmaz, Melek Karakurt;
Gürbüz, Ali Fuat;
Uğraklı, Muzaffer;
Ayçiçek, Seda Tas;
Araz, Murat;
Artaç, Mehmet

Publication type:

Article

Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors.

Published in:

Oncologist, 2025, v. 30, n. 4, p. 1, doi. 10.1093/oncolo/oyaf051

By:

Chiang, Nai-Jung;
Lee, Jih-Hsiang;
Chen, Ming-Huang;
Chao, Yee;
Su, Wu-Chou;
Bai, Li-Yuan;
Wu, Shang-Yin;
Hsu, Chih-Hung;
Shan, Yan-Shen;
Li, Chung-Pin;
Chen, Shang-Hung;
Chung, Wei-Pang;
Hao, Wei-Hua;
Chen, Li-Tzong;
Lin, Chia-Chi

Publication type:

Article

Silicon‐Based Linkers for Tunable Acid‐Sensitive Drug Release from Polymeric Nanoparticles.

Published in:

Chemistry - A European Journal, 2025, v. 31, n. 15, p. 1, doi. 10.1002/chem.202403589

By:

Timmers, Matt;
Kong, Marco;
Schuckman, Peter;
Meulemans, Tommi;
Rijcken, Cristianne;
Hennink, Wim E.;
Vermonden, Tina;
Liskamp, Rob M. J.

Publication type:

Article

Hypericin-mediated photodynamic therapy enhances gemcitabine induced Capan-2 cell apoptosis via inhibiting NADPH level.

Published in:

Journal of Pharmacy & Pharmacology, 2022, v. 74, n. 4, p. 596, doi. 10.1093/jpp/rgab073

By:

Sun, Liyun;
Shang, Huoli;
Wu, Yuzhen;
Xin, Xiujuan

Publication type:

Article

Systemowe leczenie chorych na zaawansowanego raka trzustki — czy nadal jest miejsce dla gemcytabiny w pierwszej linii? Doświadczenia polskich ośrodków.

Published in:

Gastroenterologia Kliniczna, 2024, v. 16, n. 1, p. 74, doi. 10.5603/gek.103683

By:

Raczyński, Ireneusz;
Zając, Patryk;
Streb, Joanna;
Czartoryska-Arłukowicz, Bogumiła;
Chruściana-Bołtuć, Aleksandra;
Talerczyk, Małgorzata;
Wierzbicka, Katarzyna;
Siedlaczek, Agnieszka;
Radecka, Weronika;
Jurczyk, Michał;
Radecka, Barbara

Publication type:

Article

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer.

Published in:

JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac047

By:

Arciero, Vanessa;
Luo, Jin;
Parmar, Ambica;
Dai, Wei Fang;
Beca, Jaclyn M;
Raphael, Michael J;
Isaranuwatchai, Wanrudee;
Habbous, Steven;
Tadrous, Mina;
Earle, Craig C;
Biagi, Jim J;
Mittmann, Nicole;
Arias, Jessica;
Gavura, Scott;
Chan, Kelvin K W

Publication type:

Article

Dosing Schedules of Gemcitabine and nab-Paclitaxel for Older Adults With Metastatic Pancreatic Cancer.

Published in:

JNCI Cancer Spectrum, 2021, v. 5, n. 5, p. 1, doi. 10.1093/jncics/pkab074

By:

Winer, Arthur;
Handorf, Elizabeth;
Dotan, Efrat

Publication type:

Article

LncRNA MACC1-AS1 induces gemcitabine resistance in pancreatic cancer cells through suppressing ferroptosis.

Published in:

Cell Death Discovery, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41420-024-01866-y

By:

Zhu, Jiyun;
Yu, Zehao;
Wang, Xuguang;
Zhang, Jinghui;
Chen, Yi;
Chen, Kaibo;
Zhang, Bin;
Sun, Jianhong;
Jiang, Jianshuai;
Zheng, Siming

Publication type:

Article

Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience.

Published in:

Turkish Journal of Medical Sciences, 2021, v. 51, n. 2, p. 685, doi. 10.3906/sag-2008-114

By:

BATGİ, Hikmettullah;
BAŞCI, Semih;
DAL, Mehmet Sinan;
KIZIL ÇAKAR, Merih;
UNCU ULU, Bahar;
YİĞENOĞLU, Tuğçe Nur;
ÖZCAN, Nurgül;
KILINÇ, Ali;
MERDİN, Alparslan;
YILDIZ, Jale;
BAKIRTAŞ, Mehmet;
ŞAHİN, Derya;
DARÇIN, Tahir;
İSKENDER, Dicle;
BAYSAL, Nuran Ahu;
ALTUNTAŞ, Fevzi

Publication type:

Article

Development of a Novel Ionic Liquid Based Microemulsion System for Gemcitabine Hydrochloride and in vitro Evaluation in Human Cervical Cancer HeLa Cells.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2021, v. 55, n. 3, p. 685, doi. 10.5530/ijper.55.3.140

By:

Yuanyuan Chen;
Juan Li

Publication type:

Article

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review.

Published in:

Investigative & Clinical Urology, 2021, v. 62, n. 6, p. 623, doi. 10.4111/icu.20210265

By:

Mi Ah Han;
Maisch, Philipp;
Jae Hung Jung;
Jun Eul Hwang;
Narayan, Vikram;
Cleves, Anne;
Eu Chang Hwang;
Philipp Dahm

Publication type:

Article

Efficacy and safety of gemcitabine plus S-1 vs. gemcitabine plus nab-paclitaxel in treatment-naïve advanced pancreatic ductal adenocarcinoma.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 10, p. 765, doi. 10.20892/j.issn.2095-3941.2023.0189

By:

Zhou Zhu;
Hui Tang;
Jinrong Ying;
Yuejuan Cheng;
Xiang Wang;
Yingyi Wang;
Chunmei Bai

Publication type:

Article

Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.

Published in:

Cancer Biology & Medicine, 2023, v. 20, n. 8, p. 599, doi. 10.20892/j.issn.2095-3941.2023.0039

By:

Danqi Fu;
Jingrui Yan;
Zhaoyu Zhang;
Yang Liu;
Xiaoqing Ma;
Jinsheng Ding;
Shengyu Yang;
Ran Zhao;
Antao Chang;
Chuntao Gao;
Jing Liu;
Tiansuo Zhao;
Xiuchao Wang;
Chongbiao Huang;
Song Gao;
Ying Ma;
Bo Tang;
Yukuan Feng;
Hongwei Wang;
Jihui Hao

Publication type:

Article

VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer in vivo.

Published in:

Cancer Biology & Medicine, 2021, v. 18, n. 3, p. 772, doi. 10.20892/j.issn.2095-3941.2020.0568

By:

Guangbo Kang;
Min Hu;
He Ren;
Jiewen Wang;
Xin Cheng;
Ruowei Li;
Bo Yuan;
Yasmine Balan;
Zixuan Bai;
He Huang

Publication type:

Article

Retraction Note: The BET inhibitor I-BET762 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48298-9

By:

Xie, Fang;
Huang, Mei;
Lin, Xiansheng;
Liu, Chenhai;
Liu, Zhen;
Meng, Futao;
Wang, Chao;
Huang, Qiang

Publication type:

Article

C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-34962-7

By:

Shirakawa, Tsuyoshi;
Makiyama, Akitaka;
Shimokawa, Mototsugu;
Otsuka, Taiga;
Shinohara, Yudai;
Koga, Futa;
Ueda, Yujiro;
Nakazawa, Junichi;
Otsu, Satoshi;
Komori, Azusa;
Arima, Shiho;
Fukahori, Masaru;
Taguchi, Hiroki;
Honda, Takuya;
Shibuki, Taro;
Nio, Kenta;
Ide, Yasushi;
Ureshino, Norio;
Mizuta, Toshihiko;
Mitsugi, Kenji

Publication type:

Article

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1193791

By:

Zelin Hou;
Jiajing Lin;
Yuan Ma;
Haizhong Fang;
Yuwei Wu;
Zhijiang Chen;
Xianchao Lin;
Fengchun Lu;
Shi Wen;
Xunbin Yu;
Heguang Huang;
Yu Pan

Publication type:

Article

Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1138265

By:

Zhanxue Zhao;
Linxun Liu;
Hekai Chen;
Shuai Li;
Yan Guo;
Xiaofan Hou;
Jinyu Yang

Publication type:

Article

Co-delivery of paclitaxel and gemcitabine via folic acid-conjugated polymeric multi-drug nanoparticles (FA-PMDNPs) for the treatment of breast cancer.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2020, v. 29, n. 10, p. 701, doi. 10.5246/jcps.2020.10.065

By:

Meng Lei;
Xueyuan Wang;
Hang Miao;
Jia Wang;
Sijia Sha;
Jiang Zhu;
Yongqiang Zhu

Publication type:

Article

A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 2, p. 602, doi. 10.4143/crt.2023.726

By:

Liu, Ting;
Li, Qing;
Lin, Zhen;
Liu, Chunhua;
Pu, Wei;
Zeng, Shasha;
Lai, Jun;
Cai, Xuebin;
Zhang, Lisha;
Wang, Shuyang;
Chen, Miao;
Cao, Wei;
Gou, Hongfeng;
Zhu, Qing

Publication type:

Article

Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner.

Published in:

Cancer Research & Treatment, 2024, v. 56, n. 1, p. 259, doi. 10.4143/crt.2022.1600

By:

Pei Cao;
Weigang Zhang;
Junyi Qiu;
Zuxiong Tang;
Xiaofeng Xue;
Tingting Feng

Publication type:

Article

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder.

Published in:

Cancer Research & Treatment, 2023, v. 55, n. 2, p. 636, doi. 10.4143/crt.2022.343

By:

Hongsik Kim;
Byong Chang Jeong;
Joohyun Hong;
Ghee Young Kwon;
Chan Kyo Kim;
Won Park;
Hongryull Pyo;
Wan Song;
Hyun Hwan Sung;
Jung Yong Hong;
Se Hoon Park

Publication type:

Article

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities.

Published in:

Cancer Research & Treatment, 2022, v. 54, n. 2, p. 554, doi. 10.4143/crt.2021.375

By:

Brau-Figueroa, Hasan;
Arango-Bravo, Eder;
Castro-Eguiluz, Denisse;
Galicia-Carmona, Tatiana;
Lugo-Alferez, Leopoldo Abraham;
Cruz-Bautista, Ivette;
Jiménez-Lima, Roberto;
Cetina-Pérez, Lucely

Publication type:

Article

Use of Gemcitabine Plus Carboplatin Is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5.

Published in:

Cancer Research & Treatment, 2021, v. 53, n. 4, p. 1166, doi. 10.4143/crt.2021.091

By:

Hyung-Don Kim;
Hyeon-Su Im;
Jwa Hoon Kim;
Hyehyun Jeong;
Shin Kyo Yoon;
Inkeun Park;
Jae Lyun Lee

Publication type:

Article

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer.

Published in:

Cancer Research & Treatment, 2021, v. 53, n. 4, p. 1096, doi. 10.4143/crt.2020.928

By:

Kyung-Hun Lee;
Eui Kyu Chie;
Seock-Ah Im;
Jee Hyun Kim;
Jihyun Kwon;
Sae-Won Han;
Do-Youn Oh;
Jin-Young Jang;
Jae-Sung Kim;
Tae-You Kim;
Yung-Jue Bang;
Sun Whe Kim;
Sung W. Ha

Publication type:

Article

Synergistic antitumor efficacy of gemcitabine and cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via Sp1-SAT1-polyamine metabolism pathway.

Published in:

Cellular Oncology (2211-3428), 2024, v. 47, n. 1, p. 321, doi. 10.1007/s13402-023-00870-1

By:

Wei, Wanhui;
Lu, Yuanyuan;
Hu, Qian;
Yin, Jinwen;
Wang, Youwei;
Zhang, Heng;
Zhao, Qiu;
Liu, Lan

Publication type:

Article

ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 4, p. 1085, doi. 10.1007/s13402-023-00799-5

By:

Yang, Linhua;
Wang, Hui;
Guo, Miaomiao;
He, Min;
Zhang, Wei;
Zhan, Ming;
Liu, Yingbin

Publication type:

Article

MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.

Published in:

Cellular Oncology (2211-3428), 2021, v. 44, n. 6, p. 1363, doi. 10.1007/s13402-021-00643-8

By:

Lee, Sung Hwan;
Hwang, Ho Kyoung;
Lee, Woo Jung;
Kang, Chang Moo

Publication type:

Article

Antitumour effects of a solid lipid nanoparticle loaded with gemcitabine and oxaliplatin on the viability, apoptosis, autophagy, and Hsp90 of ovarian cancer cells.

Published in:

Journal of Microencapsulation, 2022, v. 39, n. 5, p. 467, doi. 10.1080/02652048.2022.2109218

By:

Al-Mutairi, Ashwaq A.;
Alkhatib, Mayson H.

Publication type:

Article

Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer.

Published in:

Cancers, 2025, v. 17, n. 7, p. 1224, doi. 10.3390/cancers17071224

By:

Kaynak, Ahmet;
Vallabhapurapu, Subrahmanya D.;
Smith, Eric P.;
Davis, Harold W.;
Lewis, Clayton S.;
Ahn, Joseph;
Muller, Petr;
Vojtesek, Borek;
Stringer, Keith F.;
Franco, Robert S.;
Bogdanov, Vladimir Y.;
Shao, Wen-Hai;
Qi, Xiaoyang

Publication type:

Article

Impact of Surgical Resection After Induction Gemcitabine Plus S-1-Based Chemoradiotherapy in Patients with Locally Advanced Pancreatic Ductal Adenocarcinoma: A Focus on UR-LA Cases.

Published in:

Cancers, 2025, v. 17, n. 6, p. 1048, doi. 10.3390/cancers17061048

By:

Kishiwada, Masashi;
Mizuno, Shugo;
Hayasaki, Aoi;
Kaluba, Benson;
Fujii, Takehiro;
Noguchi, Daisuke;
Ito, Takahiro;
Iizawa, Yusuke;
Tanemura, Akihiro;
Murata, Yasuhiro;
Kuriyama, Naohisa

Publication type:

Article

ECM Stiffness-Induced Redox Signaling Enhances Stearoyl Gemcitabine Efficacy in Pancreatic Cancer.

Published in:

Cancers, 2025, v. 17, n. 5, p. 870, doi. 10.3390/cancers17050870

By:

Zhao, Shuqing;
Agyare, Edward;
Zhu, Xueyou;
Trevino, Jose;
Rogers, Sherise;
Velazquez-Villarreal, Enrique;
Brant, Jason;
Eliahoo, Payam;
Barajas, Jonathan;
Hoang, Ba Xuan;
Han, Bo

Publication type:

Article

Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial.

Published in:

Cancers, 2025, v. 17, n. 3, p. 532, doi. 10.3390/cancers17030532

By:

Fernández-Castillejo, Sara;
Badia, Joan;
de la Cruz-Merino, Luís;
Martín Garcia-Sáncho, Alejandro;
Carnicero-González, Fernando;
Palazón-Carrión, Natalia;
Ríos-Herranz, Eduardo;
de la Cruz-Vicente, Fátima;
Rueda-Domínguez, Antonio;
Martínez-Banaclocha, Natividad;
Gómez-Codina, José;
Labrador, Jorge;
Martínez-Madueño, Francisca;
Amigó, Núria;
Salar-Silvestre, Antonio;
Rodríguez-Abreu, Delvys;
Gálvez-Carvajal, Laura;
Sánchez-Beato, Margarita;
Provencio-Pulla, Mariano;
Guirado-Risueño, Maria

Publication type:

Article

Impact of Membranous Nectin-4 on Outcomes of Platinum-Based Chemotherapy in Metastatic Urothelial Carcinoma.

Published in:

Cancers, 2025, v. 17, n. 3, p. 433, doi. 10.3390/cancers17030433

By:

Hsueh, Fu-Jen;
Wang, Chung-Chieh;
Guo, Jhe-Cyuan;
Chueh, Shih-Chieh;
Tsai, Yu-Chieh

Publication type:

Article

Initial Use Experience of Durvalumab Plus Gemcitabine and Cisplatin for Advanced Biliary Tract Cancer in a Japanese Territory Center.

Published in:

Cancers, 2025, v. 17, n. 2, p. 314, doi. 10.3390/cancers17020314

By:

Shionoya, Kento;
Sofuni, Atsushi;
Mukai, Shuntaro;
Yamauchi, Yoshiya;
Tsuchiya, Takayoshi;
Tanaka, Reina;
Tonozuka, Ryosuke;
Yamamoto, Kenjiro;
Nagai, Kazumasa;
Matsunami, Yukitoshi;
Kojima, Hiroyuki;
Minami, Hirohito;
Hirakawa, Noriyuki;
Zhan, Qiang;
Itoi, Takao

Publication type:

Article

Cancer Therapy-Induced Cardiotoxicity: Results of the Analysis of the UK DEFINE Database.

Published in:

Cancers, 2025, v. 17, n. 2, p. 311, doi. 10.3390/cancers17020311

By:

Chan, Stefanie Ho Yi;
Fitzpatrick, Raymond W.;
Layton, Deborah;
Webley, Sherael;
Salek, Sam

Publication type:

Article

Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study.

Published in:

Cancers, 2025, v. 17, n. 2, p. 305, doi. 10.3390/cancers17020305

By:

Dayyani, Farshid;
Stirnadel-Farrant, Heide A.;
Hu, Jenny;
Lin, Yian;
Kebede, Nehemiah;
Valerio, Stephen J.;
Ahn, Daniel H.

Publication type:

Article

Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models.

Published in:

Cancers, 2025, v. 17, n. 2, p. 204, doi. 10.3390/cancers17020204

By:

Ye, Jian;
Qin, Shuyang S.;
Hughson, Angela L.;
Hannon, Gary;
Vrooman, Tara G.;
Lesch, Maggie L.;
Eckl, Sarah L.;
Benoodt, Lauren;
Mills, Bradley N.;
Lord, Edith M.;
Belt, Brian A.;
Linehan, David C.;
Luheshi, Nadia;
Eyles, Jim;
Gerber, Scott A.

Publication type:

Article

Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma.

Published in:

Cancers, 2025, v. 17, n. 1, p. 132, doi. 10.3390/cancers17010132

By:

Massa, Annamaria;
Vita, Francesca;
Peraldo-Neia, Caterina;
Varamo, Chiara;
Basiricò, Marco;
Raggi, Chiara;
Bernabei, Paola;
Erriquez, Jessica;
Leone, Francesco;
Aglietta, Massimo;
Cavalloni, Giuliana;
Marchiò, Serena

Publication type:

Article

Correction: Patel et al. Palmitoyl Carnitine-Anchored Nanoliposomes for Neovasculature-Specific Delivery of Gemcitabine Elaidate to Treat Pancreatic Cancer. Cancers 2023, 15 , 182.

Published in:

2025

By:

Patel, Akanksha;
Saraswat, Aishwarya;
Patel, Harsh;
Chen, Zhe-Sheng;
Patel, Ketan

Publication type:

Correction Notice

Sequential Endoluminal Doxorubicin and Gemcitabine Alternating Weekly with Sequential Mitomycin and Docetaxel for Recurrent Non-Muscle Invasive Urothelial Carcinoma.

Published in:

Cancers, 2024, v. 16, n. 24, p. 4126, doi. 10.3390/cancers16244126

By:

McElree, Ian M.;
Packiam, Vignesh T.;
Steinberg, Ryan L.;
Hougen, Helen Y.;
Abou Chakra, Mohamad;
Mott, Sarah L.;
O'Donnell, Michael A.

Publication type:

Article

Comparisons of Intravesical Treatments with Mitomycin C, Gemcitabine, and Docetaxel for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-Analysis.

Published in:

Cancers, 2024, v. 16, n. 24, p. 4125, doi. 10.3390/cancers16244125

By:

Matloubieh, Jubin E.;
Hanelin, David;
Agalliu, Ilir

Publication type:

Article

Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal Adenocarcinoma.

Published in:

Cancers, 2024, v. 16, n. 23, p. 3945, doi. 10.3390/cancers16233945

By:

Kluz, Natalia;
Kraj, Leszek;
Chmiel, Paulina;
Przybyłkowski, Adam M.;
Wyrwicz, Lucjan;
Stec, Rafał;
Szymański, Łukasz

Publication type:

Article

Altered Mechanobiology of PDAC Cells with Acquired Chemoresistance to Gemcitabine and Paclitaxel.

Published in:

Cancers, 2024, v. 16, n. 22, p. 3863, doi. 10.3390/cancers16223863

By:

Gregori, Alessandro;
Bergonzini, Cecilia;
Capula, Mjriam;
de Mercado, Rick Rodrigues;
Danen, Erik H. J.;
Giovannetti, Elisa;
Schmidt, Thomas

Publication type:

Article

TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness.

Published in:

Cancers, 2024, v. 16, n. 21, p. 3705, doi. 10.3390/cancers16213705

By:

di Miceli, Noemi;
Baioni, Chiara;
Barbieri, Linda;
Danielli, Davide;
Sala, Emiliano;
Salvioni, Lucia;
Garbujo, Stefania;
Colombo, Miriam;
Prosperi, Davide;
Innocenti, Metello;
Fiandra, Luisa

Publication type:

Article

Comparative Efficacy of 21 Treatment Strategies for Resectable Pancreatic Cancer: A Network Meta-Analysis.

Published in:

Cancers, 2024, v. 16, n. 18, p. 3203, doi. 10.3390/cancers16183203

By:

Petrelli, Fausto;
Rosenfeld, Roberto;
Ghidini, Antonio;
Celotti, Andrea;
Dottorini, Lorenzo;
Viti, Matteo;
Baiocchi, Gianluca;
Garrone, Ornella;
Tomasello, Gianluca;
Ghidini, Michele

Publication type:

Article

Real-World Outcomes of First-Line Chemotherapy in Metastatic Pancreatic Cancer: A Nationwide Population-Based Study in Korea.

Published in:

Cancers, 2024, v. 16, n. 18, p. 3173, doi. 10.3390/cancers16183173

By:

Park, Chan Su;
Park, Byung Kyu;
Han, Joung-Ho;
Lee, Kyong Joo;
Son, Kang Ju

Publication type:

Article